David P Perry - Net Worth and Insider Trading
David P Perry Net Worth
The estimated net worth of David P Perry is at least $3 Million dollars as of 2024-11-29. David P Perry is the President and CEO of Anacor Pharmaceuticals Inc and owns about 261,154 shares of Anacor Pharmaceuticals Inc (ANAC) stock worth over $3 Million. David P Perry is also the Executive Chairman, 10% Owner of Better Therapeutics Inc and owns about 17,082,779 shares of Better Therapeutics Inc (BTTX) stock worth over $1,708. Details can be seen in David P Perry's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David P Perry has not made any transactions after 2023-07-27 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of David P Perry
David P Perry Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David P Perry owns 4 companies in total, including Evelo Biosciences Inc (EVLO) , Anacor Pharmaceuticals Inc (ANAC) , and Better Therapeutics Inc (BTTX) among others .
Click here to see the complete history of David P Perry’s form 4 insider trades.
Insider Ownership Summary of David P Perry
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| EVLO | Evelo Biosciences Inc | 2018-05-08 | director |
| ANAC | Anacor Pharmaceuticals Inc | 2014-03-04 | director & President and CEO |
| BTTX | Better Therapeutics Inc | 2023-07-27 | director & 10 percent owner & See Remarks |
 | | 2021-10-28 | director & 10 percent owner & See Remarks |
David P Perry Latest Holdings Summary
David P Perry currently owns a total of 2 stocks. Among these stocks, David P Perry owns 261,154 shares of Anacor Pharmaceuticals Inc (ANAC) as of November 23, 2010, with a value of $3 Million and a weighting of 99.93%. David P Perry also owns 17,082,779 shares of Better Therapeutics Inc (BTTX) as of July 27, 2023, with a value of $1,708 and a weighting of 0.07%.
Latest Holdings of David P Perry
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ANAC | Anacor Pharmaceuticals Inc | 2010-11-23 | 261,154 | 9.82 | 2,564,532 |
| BTTX | Better Therapeutics Inc | 2023-07-27 | 17,082,779 | 0.00 | 1,708 |
Holding Weightings of David P Perry
David P Perry Form 4 Trading Tracker
According to the SEC Form 4 filings, David P Perry has made a total of 0 transactions in Anacor Pharmaceuticals Inc (ANAC) over the past 5 years. The most-recent trade in Anacor Pharmaceuticals Inc is the sale of 0 shares on November 23, 2010, which brought David P Perry around $0.
According to the SEC Form 4 filings, David P Perry has made a total of 4 transactions in Better Therapeutics Inc (BTTX) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in Better Therapeutics Inc is the acquisition of 1,233,045 shares on July 27, 2023, which cost David P Perry around $900,123.
Insider Trading History of David P Perry
- 1
David P Perry Trading Performance
GuruFocus tracks the stock performance after each of David P Perry's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David P Perry is -45.95%. GuruFocus also compares David P Perry's trading performance to market benchmark return within the same time period. The performance of stocks bought by David P Perry within 3 months outperforms 0 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how David P Perry's insider trading performs compared to the benchmark.
Performance of David P Perry
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -21.07 | | | | | |
| Relative Return to S&P 500(%) | -17.83 | | | | | |
David P Perry Ownership Network
David P Perry Owned Company Details
What does Evelo Biosciences Inc do?
Who are the key executives at Evelo Biosciences Inc?
David P Perry is the director of Evelo Biosciences Inc. Other key executives at Evelo Biosciences Inc include Chief Medical Officer Duncan Mchale , Chief Financial Officer Marella Thorell , and See Remarks Mark Bodmer .
Evelo Biosciences Inc (EVLO) Insider Trades Summary
Over the past 18 months, David P Perry made no insider transaction in Evelo Biosciences Inc (EVLO). Other recent insider transactions involving Evelo Biosciences Inc (EVLO) include a net sale of 13,391 shares made by Duncan Mchale , a net sale of 13,145 shares made by Mark Bodmer , and a net sale of 7,814 shares made by Marella Thorell .
In summary, during the past 3 months, insiders sold 0 shares of Evelo Biosciences Inc (EVLO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 36,860 shares of Evelo Biosciences Inc (EVLO) were sold and 5,411,255 shares were bought by its insiders, resulting in a net purchase of 5,374,395 shares.
Evelo Biosciences Inc (EVLO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Evelo Biosciences Inc Insider Transactions
David P Perry Mailing Address
Above is the net worth, insider trading, and ownership report for David P Perry. You might contact David P Perry via mailing address: 1020 East Meadow Circle, Palo Alto Ca 94303.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
